Cullinan Therapeutics, Inc.
CGEM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$168 | -$153 | $109 | -$67 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $3 |
| Stock-Based Comp. | $38 | $30 | $28 | $24 |
| Change in WC | -$0 | -$0 | $11 | -$4 |
| Other Non-Cash | -$15 | -$12 | -$275 | $0 |
| Operating Cash Flow | -$145 | -$134 | -$127 | -$43 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | -$1 | -$1 |
| Net Acquisitions | $0 | -$0 | $275 | $1 |
| Inv. Purchases | -$721 | -$373 | -$378 | -$526 |
| Inv. Sales/Matur. | $585 | $409 | $353 | $192 |
| Other Inv. Act. | $0 | $0 | $0 | -$0 |
| Investing Cash Flow | -$136 | $36 | $249 | -$334 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $2 | -$2 | $0 |
| Stock Issued | $263 | $38 | $8 | $267 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $4 | $1 | -$32 | $2 |
| Financing Cash Flow | $266 | $41 | -$26 | $269 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$15 | -$58 | $96 | -$108 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $98 | $156 | $60 | $168 |
| End Cash | $83 | $98 | $156 | $60 |
| Free Cash Flow | -$145 | -$134 | -$128 | -$44 |